About Acologix
Acologix is a company based in Hayward (United States) founded in 1992. Acologix has raised $69.8 million across 2 funding rounds from investors including Tokio Marine Holdings, Nomura and SoftBank. The company has 13 employees as of December 31, 2010. Acologix operates in a competitive market with competitors including Marizyme, AFYX Therapeutics, AB-Biotics, OraPharma and IntraBiotics Pharmaceuticals, among others.
- Headquarter Hayward, United States
- Employees 13 as on 31 Dec, 2010
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Acologix, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$69.8 M (USD)
in 2 rounds
-
Latest Funding Round
$29.8 M (USD), Series C
Feb 14, 2006
-
Investors
Tokio Marine Holdings
& 4 more
-
Employee Count
13
as on Dec 31, 2010
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Acologix
Acologix has successfully raised a total of $69.8M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $29.8 million completed in February 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Acologix
Acologix has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Tokio Marine Holdings, Nomura and SoftBank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
PE and VC fund focused on fintech, Adtech, gaming, eCommerce, and multiple sectors
|
Locked | Locked | Locked | |
|
Diversified asset management services are offered globally by the firm.
|
Locked | Locked | Locked |
Investor details for Acologix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acologix
Investment portfolio details for Acologix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acologix
Detailed financials for Acologix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acologix Comparisons
Peer comparison for Acologix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acologix
Acologix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Marizyme, AFYX Therapeutics, AB-Biotics, OraPharma and IntraBiotics Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for chronic wounds, thrombolysis, and dental health are developed.
|
|
| Locked | Locked | Locked |
Drug patches for mucosal disease treatments are developed.
|
|
| Locked | Locked | Locked |
Probiotic drugs for dental disorders and nutraceuticals are developed.
|
|
| Locked | Locked | Locked |
Oral health products for treatment and maintenance are developed.
|
|
| Locked | Locked | Locked |
Antibiotics for oral mucositis in head-and-neck cancer patients are developed.
|
Detailed competitors of Acologix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acologix
Complete news archive for Acologix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acologix
Acologix was founded in 1992 and raised its 1st funding round 12 years after it was founded.
Acologix is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Acologix is a funded company, having raised a total of $69.8M across 2 funding rounds to date.
As of Dec 31, 2010, the latest employee count at Acologix is 13.
Acologix was founded in 1992 and is based in Hayward, United States. Therapeutics are developed by the company for metabolic disorders affecting kidney and bone functions. Research is focused on mineral metabolism and extracellular matrix molecules that support bone and connective tissue. AC-100 (Dentonin) is being advanced for periodontal defect repair and dental restorations. Phosphatonin is under development to address hyperphosphatemia and related issues in chronic kidney disease patients.
Acologix's top competitors include Marizyme, AFYX Therapeutics and AB-Biotics.
Acologix has 5 investors. Key investors include Tokio Marine Holdings, Nomura, SoftBank, SMBC Venture Capital, and JAIC America.